Technology area: Medical Devices & Mechanical Engineering
12 pending office actions • 3 clients • 12 examiners • 6 art units • 0 of 12 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
DUNLAP CODDING, P.C. - Novocure GmbH handles Medical Devices & Mechanical Engineering matters and has 12 pending office actions. The associated firm profile records 4705 career applications, placing this client-specific workload within an established prosecution portfolio.
The resolved allowance rate is 71.14%. Allowed matters average 2.94 office actions per allowance, indicating that successful cases commonly involve several examination exchanges. Practitioners can use the data to distinguish the current client workload from the firm’s broader activity while planning responses for medical-device and mechanical claims.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (42%) |
| Multi-statute (no §101) | 7 (58%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SISON, CHRISTINE ANDREA PAN | 1 | 32.7% | +40.7% |
| STUMPFOLL, DANA LYNN | 1 | 54.1% | +43.9% |
| HILSMIER, HEIDI ANN | 1 | 53.8% | +65.9% |
| SOLOMON, JOSHUA BRENDON | 1 | 83.5% | +20.2% |
| DINH, ANH-KHOA N | 1 | 87.3% | +16.1% |
| DEBERRY, REGINA M | 1 | 50.2% | +30.8% |
| EVANISKO, GEORGE ROBERT | 1 | 70.4% | +34.9% |
| MARLEN, TAMMIE K | 1 | 75.3% | +20.8% |
| SAHAND, SANA | 1 | 63.5% | +24.0% |
| TEHRANI, DANIEL | 1 | 60.9% | +41.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18398714 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-VEGFR-2 ANTIBODIES | DINH, ANH-KHOA N | 34d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18899709 | TRANSDUCER ARRAY HAVING SUBARRAYS AND METHODS OF PRODUCTION AND USE THEREOF | SISON, CHRISTINE ANDREA PAN | — |
| 18894349 | LOW FREQUENCY RF ABLATION SYSTEM | STUMPFOLL, DANA LYNN | — |
| 18743392 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND THIOREDOXIN/GLUTATHIONE INHIBITORS | HILSMIER, HEIDI ANN | — |
| 18619957 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS | SOLOMON, JOSHUA BRENDON | — |
| 18477010 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND DENDRITIC CELLS | DEBERRY, REGINA M | — |
| 18333906 | SYSTEMS AND METHODS FOR INCREASING INTESTINAL ABSORPTION OF THERAPEUTIC AGENTS | EVANISKO, GEORGE ROBERT | — |
| 17813837 | CONDUCTIVE PAD GENERATING TUMOR TREATING FIELD AND METHODS OF PRODUCTION AND USE THEREOF | MOSS, JAMES R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18062372 | GARMENT PROVIDING A BIASING FORCE ON A TRANSDUCER ARRAY | SAHAND, SANA | 8d overdue |
| 18398714 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-VEGFR-2 ANTIBODIES | DINH, ANH-KHOA N | 34d |
| 18899709 | TRANSDUCER ARRAY HAVING SUBARRAYS AND METHODS OF PRODUCTION AND USE THEREOF | SISON, CHRISTINE ANDREA PAN | — |
| 18894349 | LOW FREQUENCY RF ABLATION SYSTEM | STUMPFOLL, DANA LYNN | — |
| 18743392 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND THIOREDOXIN/GLUTATHIONE INHIBITORS | HILSMIER, HEIDI ANN | — |
| 18619957 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS | SOLOMON, JOSHUA BRENDON | — |
| 18477010 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND DENDRITIC CELLS | DEBERRY, REGINA M | — |
| 18333906 | SYSTEMS AND METHODS FOR INCREASING INTESTINAL ABSORPTION OF THERAPEUTIC AGENTS | EVANISKO, GEORGE ROBERT | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Novocure | 10 |
| Novocure GmbH G | 1 |
| Novocure GmbH | 1 |
| Art Unit | Apps |
|---|---|
| 3796 | 5 |
| 3792 | 3 |
| 3794 | 1 |
| 1647 | 1 |
| 3700 | 1 |
| 2189 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18899709 | TRANSDUCER ARRAY HAVING SUBARRAYS AND METHODS OF PRODUCTION AND USE THEREOF | Novocure GmbH | SISON, CHRISTINE ANDREA PAN | 3796 | §103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18894349 | LOW FREQUENCY RF ABLATION SYSTEM | Novocure GmbH | STUMPFOLL, DANA LYNN | 3794 | §102§103 | Non-Final OA | — | Pending | Sep 24, 2024 |
| 18743392 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND THIOREDOXIN/GLUTATHIONE INHIBITORS | Novocure GmbH G | HILSMIER, HEIDI ANN | 3796 | §103§112 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18619957 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS | Novocure GmbH | SOLOMON, JOSHUA BRENDON | 3792 | §102§103 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18398714 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-VEGFR-2 ANTIBODIES | Novocure GmbH | DINH, ANH-KHOA N | 3796 | §103 | Non-Final OA | 34d | Pending | Dec 28, 2023 |
| 18477010 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND DENDRITIC CELLS | Novocure GmbH | DEBERRY, REGINA M | 1647 | §102§103§112 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18333906 | SYSTEMS AND METHODS FOR INCREASING INTESTINAL ABSORPTION OF THERAPEUTIC AGENTS | Novocure GmbH | EVANISKO, GEORGE ROBERT | 3792 | §102§103§112Other | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18063464 | COMPRESSION GARMENT ASSEMBLY FOR APPLYING TTFIELDS AND METHODS OF PRODUCTION AND USE THEREOF | Novocure GmbH | MARLEN, TAMMIE K | 3796 | §103 | Final Rejection | — | Pending | Dec 08, 2022 |
| 18062372 | GARMENT PROVIDING A BIASING FORCE ON A TRANSDUCER ARRAY | Novocure GmbH | SAHAND, SANA | 3796 | §103 | Non-Final OA | 8d overdue | Pending | Dec 06, 2022 |
| 18062161 | COMPACT DC SYSTEM FOR DELIVERING A SQUARE WAVE AC SIGNAL | Novocure GmbH | TEHRANI, DANIEL | 3792 | §103 | Non-Final OA | — | Pending | Dec 06, 2022 |
| 17813837 | CONDUCTIVE PAD GENERATING TUMOR TREATING FIELD AND METHODS OF PRODUCTION AND USE THEREOF | Novocure GmbH | MOSS, JAMES R | 3700 | §103§112 | Non-Final OA | — | Pending | Jul 20, 2022 |
| 17698777 | CONSTRUCTING A 3D PHANTOM WITH LIQUID HYDROGEL | Novocure GmbH | CALLE, ANGEL JAVIER | 2189 | §103 | Final Rejection | 3d overdue | Pending | Mar 18, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial71.1% of resolved applications prosecuted by Dunlap Codding, P.C. - Novocure GmbH were allowed, across 4,705 applications in USPTO records.
2.94 office actions per allowed application on average.
12 pending office actions as of October 2026, for 3 clients, before 12 examiners in 6 art units.
